Brief: Biora Therapeutics Further Reduces Net Debt And Monetizes Legacy Asset
11/03/2024 13:02
March 11 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS FURTHER REDUCES NET DEBT AND MONETIZES
LEGACY
ASSET
* BIORA THERAPEUTICS - ON MARCH 8, BIORA SOLD ITS MINORITY
STAKE
TO ENUMERA INVESTORS FOR $3 MILLION
* BIORA THERAPEUTICS - AGREEMENT WITH INSTITUTIONAL INVESTOR
CONTEXT CAPITAL TO INVEST $2.8 MILLION IN NEW CAPITAL ALONGSIDE
A CONVERTIBLE NOTE EXCHANGE
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules